Cotinga Pharmaceuticals Inc COT

Primary Symbol: COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Post by stockhound2on Jul 27, 2009 11:45am

270 Views

Post# 16168504

wow didn't expect this

thought it might pull off a bit but not this much we beat yes revenues wern't great but it wasn't a disaster.

I thought this would rise currency will help this qtr

Bullboard Posts

Gold vs. bitcoin, where should you invest?